Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides

Author： Dias N.   Stein C.A.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.54, Iss.3, 2002-11, pp. : 263-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2'-Modified Oligonucleotides for Antisense Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-04 ,pp. : 641-649

Bentham Science Publishers

Access to resources Recommend Favorite

Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases

By  

Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-11 ,pp. : 211-230

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-01 ,pp. : 463-470

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Potential of Respirable Antisense Oligonucleotides (RASONs) in Asthma

By Ball H.A.   Sandrasagra A.   Tang L.   Van Scott M.   Wild J.   Nyce J.W.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 2, 2003-01 ,pp. : 97-106

Adis International

Access to resources Recommend Favorite

Antisense oligonucleotides: local delivery enhances their therapeutic potential

By Nyce J.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 263-267

Informa Healthcare

Access to resources Recommend Favorite